Hodgkin lymphoma: open trials in Russia

• NCT06812858

  PD-1 Inhibitors Maintenance for cHL Post-autoHCT

  Trial Treatment · Phase 2 · St. Petersburg State Pavlov Medical University

  National Medical and Surgical Center named after N.I. Pirogov, Moscow · RecruitingP. Hertsen Moscow Oncology Research Institute (MORI) for administrative and economic work - the branch of the FSBI "National Medical Research Radiological Centre" (NMRRC) of the Ministry of Health of the Russian Federation, Moscow · RM Gorbacheva Research Institute, Pavlov University, Saint Petersburg

  Registry updated 2026-05-22

• NCT07234487

  Comparison of AVD + Low-Dose Nivolumab vs. PET-Adapted BEACOPP-like in Advanced cHL

  Trial Treatment · Phase 2 · St. Petersburg State Pavlov Medical University

  A.N.Bakulev Center for cardiovascular surgery of the Russian Ministry of Health, Moscow · National Medical and Surgical Center named after N.I. Pirogov, Moscow · St. Petersburg State Pavlov Medical University, Saint Petersburg

  Registry updated 2026-04-01

• NCT06984146

  Nivo40-AVD for Advanced Classic Hodgkin Lymphoma

  Trial Treatment · Phase 2 · National Medical Research Radiological Centre of the Ministry of Health of Russia

  P. Hertsen Moscow Oncology Research Institute (MORI) for administrative and economic work - the branch of the FSBI "National Medical Research Radiological Centre" (NMRRC) of the Ministry of Health of the Russian Federation, Moscow

  Registry updated 2025-11-26

• NCT07209059

  PET-Adapted First-Line Therapy With Nivolumab for Advanced Hodgkin Lymphoma

  Trial Treatment · Phase 2 · National Research Center for Hematology, Russia

  National Medical Research Center for Hematology, Moscow

  Registry updated 2025-10-06

• NCT06931613

  Autologous Hematopoietic Stem Cell Transplantation in Pediatric Relapsed or Refractory Hodgkin Lymphoma After Nivolumab Treatment

  Trial Treatment · Phase 2 · St. Petersburg State Pavlov Medical University

  N. N. Blokhin Russian Cancer Research Center, Moscow, Russia, Moscow · Pavlov University, RM Gorbacheva Research Institute, Saint Petersburg

  Registry updated 2025-04-17

• NCT04638790

  First Line Chemotherapy for Classical Hodgkin Lymphoma in Russia (HL-Russia-1)

  Trial Treatment · Phase 3 · State Budgetary Healthcare Institution, National Medical Surgical Center N.A. N.I. Pirogov, Ministry of Health of Russia

  The Federal Budget-Funded Institution National Medical Surgical Center named after N. I. Pirogov of the Ministry of health of the Russian Federation, Moscow

  Registry updated 2024-09-27

All Hodgkin lymphoma trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error